ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,576.98
0.07%
US Tech 100
19,930.80
0.19%
Dow Jones
39,291.97
-0.13%
Brent Oil
84.265
-0.51%
Bitcoin
57,833.35
-0.32%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. ArriVent BioPharma Inc (AVBP) Quote

ArriVent BioPharma Inc

ArriVent BioPharma Inc (AVBP)

NASDAQ
18.42
-0.24
(-1.29%)
Closed July 09 4:00PM
Delayed by 15 minutes
18.42
-0.19
(-1.02%)
After Hours: 5:30PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
18.42
Bid
10.80
Ask
24.11
Volume
48,173
18.08 Day's Range 18.85
14.35 52 Week Range 25.5076
Market Cap
624.993M
Previous Close
18.66
Open
18.55
Last Trade
393
@
18.42
(formt)
Last Trade Time
Financial Volume
$ 893,703
VWAP
18.5519
Average Volume (3m)
76,938
Shares Outstanding
33,493,750
Dividend Yield
-
PE Ratio
-8.99
Earnings Per Share (EPS)
-2.07
Revenue
-
Net Profit
-69.33M

About ArriVent BioPharma Inc

ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therap... ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therapies for non-small-cell lung cancer (NSCLC) and other solid tumors. The company develops Furmonertinib, an epidermal growth factor receptor mutant-selective tyrosine kinase inhibitor that is in phase 3 clinical trial for the treatment of NSCLC patients; and ARR-002. It has strategic collaborations with Aarvik Therapeutics Inc. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
arrivent.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
ArriVent BioPharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AVBP. The last closing price for ArriVent BioPharma was $18.66. Over the last year, ArriVent BioPharma shares have traded in a share price range of $ 14.35 to $ 25.5076.

ArriVent BioPharma currently has 33,493,750 shares outstanding. The market capitalization of ArriVent BioPharma is $624.99 million. ArriVent BioPharma has a price to earnings ratio (PE ratio) of -8.99.

AVBP Latest News

More News

Form 8-K/A - Current report: [Amend]

6 hours ago
Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]

6 hours ago
Edgar (US Regulatory)

Form 8-K - Current report

June 05 2024
Edgar (US Regulatory)

ArriVent Announces a Multi-Target ADC Collaboration with Alphamab

Collaboration will leverage Alphamab’s antibody drug conjugate (“ADC”) research and discovery platform and ArriVent’s global development and commercialization expertise Upfront and milestone...

June 05 2024
GlobeNewswire Inc.

Form 8-K - Current report

May 16 2024
Edgar (US Regulatory)

ArriVent Appoints John Hohneker, M.D., to its Board of Directors

NEWTON SQUARE, Pa., May 16, 2024 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc., a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical...

May 16 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 08 2024
Edgar (US Regulatory)

Form 8-K - Current report

May 08 2024
Edgar (US Regulatory)

ArriVent BioPharma Reports First Quarter 2024 Financial Results

Presented preclinical firmonertinib (formerly furmonertinib) data at the 2024 American Association for Cancer Research (“AACR”) Annual MeetingDosed first patient in Phase 1b combination study of...

May 08 2024
GlobeNewswire Inc.

ArriVent Appoints Kristine Peterson to its Board of Directors

NEWTON SQUARE, Pa., April 22, 2024 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc., a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical...

April 22 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.241.320132013218.1819.9117.296885118.53633397CS
4-0.31-1.6550987720218.7319.9115.537893918.12424704CS
121.46998.6719252393816.95012114.357693817.39201508CS
26-5.58-23.252425.507614.3514880619.08878378CS
52-5.58-23.252425.507614.3514880619.08878378CS
156-5.58-23.252425.507614.3514880619.08878378CS
260-5.58-23.252425.507614.3514880619.08878378CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SNGXSoligenix Inc
$ 7.42
(271.00%)
134.15M
ZAPPZapp Electric Vehicles Group Ltd
$ 17.9001
(93.72%)
45.5M
PEGYPineapple Energy Inc
$ 2.30
(91.67%)
77.57M
ATNF180 Life Sciences Corporation
$ 2.9017
(79.12%)
31.21M
QUREuniQure NV
$ 6.65
(75.93%)
51.49M
NVOSNovo Integrated Sciences Inc
$ 0.4874
(-35.44%)
3.12M
FAASDigiAsia Corporation
$ 3.65
(-34.17%)
49.17k
INDVIndivior PLC
$ 10.18
(-33.64%)
2.95M
CLEUChina Liberal Education Holdings Ltd
$ 0.3905
(-31.59%)
9.24M
HUBCWHub Cyber Security Ltd
$ 0.0165
(-31.25%)
1.9k
NVDANVIDIA Corporation
$ 131.38
(2.48%)
287.03M
MAXNMaxeon Solar Technologies Ltd
$ 0.2451
(-9.22%)
233.65M
TSLATesla Inc
$ 262.33
(3.71%)
160.74M
SNGXSoligenix Inc
$ 7.42
(271.00%)
134.15M
INTCIntel Corporation
$ 34.59
(1.77%)
97.8M

Discussion

View Full Feed
ProLiberty ProLiberty 4 minutes ago
Don't know but every share they buy now below $1 is one they don't have to pay $6 for.
AMRN
blackhawks blackhawks 5 minutes ago
GOATS AND SODA

Sounds like the topics for a future Trump riff. 😏

Fact check: The theory that SARS-CoV-2 is becoming milder
JANUARY 14, 2022 1:22 PM ET

Michaeleen Doucleff 2016 square

https://www.npr.org/sections/goatsandsoda/
Zorax Zorax 5 minutes ago
Gosh, what are those square gray things on either side of shittypants? Those must be bullet proof protectors because shitface never never uses teleprompters say all his minions.
spartex spartex 6 minutes ago
Hah, funny. Are you a RedSox fan? Mitt Romney fan too? That thought? Which thought? Does it have a name or proper noun? lol

You guys are total flamers of new people showing up here. Like you are wearing flamethrowing guns. Kind of super amped.

I wonder why
PORKER PIG - SGR PORKER PIG - SGR 6 minutes ago
OINK OINk fact is DTC did OINKING decreeeeeeeeeeeeeease!! Oink Oinkkkkkkkkkkkkkkkkkkkkkkk! and hesg or whatever this ticker is does have an oooooooooooooooooiking transfer oink agent oink oink.

Feels so OOOOOOOOOOOOOOINKING gooooood OINK OINK!! Oink.
HESG
cableguy cableguy 7 minutes ago
so they, the chartists are essentially lying to us all

No not at all, not even a little bit of lying, As I said before day traders propel a stock or lower it, those that don't believe should study the charting system and daily protocol, I DID and I SAW how several chart patterns/setti
RONN
THEBEASTMUGABI THEBEASTMUGABI 8 minutes ago
Ray, how many freaking buildings has he moved into over the past dozen years ? ( for expansion) Not trying to rain on a parade but this is freakin ground hog day man. Sorry, I try not to comment anymore. I’m not involved. Just get frustrated for those that are involved.
KBLB
JOHNNIEBG JOHNNIEBG 8 minutes ago
Have no fear, President Harris and VP Michelle Obama will take care of it for you.. The ALREADY GREAT AMERICA will be even greater come NOvember. Imagine 2 women running the country. Imagine what Donnie is going to say since he hates all women leaders because he can't grab them by the crotch...
DJT
Suprfreek Suprfreek 8 minutes ago
GOP House Committee passed a bill that would stop rescheduling. Sorry having trouble posting article from M Moment.
TCNNF
TRAPPER JIM TRAPPER JIM 8 minutes ago
The lower the better for my mortgage payment. We got word that they are scheduled to break ground on our new house next week. WOOHOO
leverage102 leverage102 9 minutes ago
NSAV $$$..
How long ago was the Judgement >. * Not that Dennis / Kevin * is very concerned about, Their sites are aimed higher $$$. BILLIONS $$. Once the PPS goes up, their Stock is worth More too , they are all looking to get rich $$$$$. SO ARE WE $$$$$$$
NSAV
bud_fox bud_fox 9 minutes ago
There has never, ever been a breakout due to a chart setup with this stock, PERIOD. Just some fluff moves based on fluff news...
VXIT
cadillacdave cadillacdave 10 minutes ago
You ask who predicted NVDA would be here at this point. I called NVDA at $160 (pre-split price $1600), in November 2023.

We came very close to that already, and will likely hit that or higher before years end.
NVDA
TRAPPER JIM TRAPPER JIM 10 minutes ago
$300 million dollars raised for the benefit of clients
RSPI
KILLAZILLA KILLAZILLA 11 minutes ago
GARBAGE POST WITH ZERO LINKS=GARBAGE!!!!
WDLF
peafunke peafunke 12 minutes ago
… not you
TPTW
Mophron Mophron 12 minutes ago
Great summary. Love it.
ELTP
rayovac812 rayovac812 12 minutes ago
This guy switches from building to building.

Is that a vote to not expand in and into Lam Dong? If they start producing in Cambodia, I imagine they will need some buildings there too. It isn't as much of a switch to new buildings as much as it is expansion to produce more and more
KBLB
jbog jbog 12 minutes ago
Dew,

There is a decent history of Pfizers upper group all moving on in their 60's. I think McKinnell, Kindler and Read all left in their mid sixties, We'll see how long Bourla stays around.
JOHNNIEBG JOHNNIEBG 13 minutes ago
The conservative Heritage Foundation maintains a database, dating to 1979, that it says includes a “sampling” of election-fraud cases brought by prosecutors.

A recent search of the Heritage database found 85 cases involving allegations of noncitizen voting from 2002 to 2023
DJT
dstock07734 dstock07734 13 minutes ago
ILT,

That's not what I meant. But I like your thought. My main point here is that even a BP like Roche would not present something on a drug under RA review at the risk of being blamed for promoting unlicensed medicine which may completely derail its plan on approval. How could NWBO a
NWBO
Mophron Mophron 13 minutes ago
Was waiting for this one lol.
ELTP
cjstocksup cjstocksup 14 minutes ago
They have never once told me in the hundreds of times I have appealed. Most email replies back happen in a millisecond. They just say my account was permanently suspended on 1/8/2021. About the same time as Trump's and all the attorneys who were working on Jan. 6th were taken down also.
Which
Dead On Arrival Dead On Arrival 14 minutes ago
I met him in NYC in 2014 and he was till involved with Niocorp. Very nice guy who enjoyed talking about the company and his family. I was with another investor and we both thought we were going to be rich off this investment. Never expected the company stock price to be where it is today.
NB
ilovetech ilovetech 14 minutes ago
Look at it this way. They say it takes a good 10 years to build a successful business. Well, at least before the viral internet craze. So 9.5 years is right in line to reward you for your resilience.
NWBO

Your Recent History

NASDAQ
AVBP
ArriVent BioPharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved